Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Biohaven

Explore full profile

Pioneering transformative treatments for neuroscience and immunology disorders

New Haven, United StatesFounded 2014Biotech & Life Sciences
Valuation $1.97B Market cap · Aug/2026

At a glance

Founded
2014
Headquarters
New Haven, United States
Listing
IPO 2017
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom
News Serina raises up to $63.3M for Parkinson's candidate SER-252 Aug 1, 2026

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Portage Biotech

Series A5 investors entered at this stage

Series B and later1 investor entered at this stage

  • Yale University

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · New Haven HQ
Book a demo for the full country breakdown
Web traffic by country
17K monthly visits
across markets
🇺🇸 United States47.1%
🏳️ Korea17.1%
🏳️ Republic of10.6%
🇬🇧 United Kingdom8.8%
🇮🇳 India7.6%
Top 5 markets shown

Patents

Estimated portfolio value
$76M

66 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Biohaven was the backer or acquirer, 2016–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

5 deals across Biohaven's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Biohaven's portfolio, mapped.

        Stage
        Period
        5 of 5 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Biohaven on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Biohaven on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles